![Dennis Hom](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dennis Hom
Director Financiero/CFO en
PROQR THERAPEUTICS N.V.
.
Perfil
Dennis Hom currently works at ProQR Therapeutics NV, as Chief Financial Officer from 2025.
Mr. Hom also formerly worked at Amgen, Inc., as Executive Director-Corporate Development from 2011 to 2012, Achaogen, Inc., as Vice President-Finance & Corporate Development from 2013 to 2014, and Sagimet Biosciences, Inc., as CFO & Head-Corporate Development from 2017 to 2023.
Mr. Hom received his undergraduate degree from Massachusetts Institute of Technology.
Cargos activos de Dennis Hom
| Empresas | Cargo | Inicio |
|---|---|---|
| PROQR THERAPEUTICS N.V. | Director Financiero/CFO | 14/04/2025 |
Antiguos cargos conocidos de Dennis Hom.
| Empresas | Cargo | Fin |
|---|---|---|
| SAGIMET BIOSCIENCES INC. | Director Financiero/CFO | 01/08/2023 |
| ACHAOGEN | Director Financiero/CFO | 31/03/2014 |
| AMGEN INC. | Corporate Officer/Principal | 01/01/2012 |
Formación de Dennis Hom.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
61
Relaciones de 1er grado
5
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Achaogen, Inc.
 Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Operates as a a biopharmaceutical company, which engages in the research, development, and commercialization of antibacterial treatments for multi-drug resistant (MDR) gram-negative infections | Health Technology |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Sagimet Biosciences, Inc.
 Sagimet Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel therapeutics for the treatment of infectious diseases | Health Technology |
ProQR Therapeutics NV
 ProQR Therapeutics NV Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company with interest in the discovery and development of therapeutics for the treatment of genetic disorders | Health Technology |
- Bolsa de valores
- Insiders
- Dennis Hom
